Biop Medical
Early and Accurate Detection of Cervical Cancer
Company Overview
Snapshot
Founded in December 2012, Biop Medical operated with 1–10 employees. The company secured funding across three rounds, totaling $4.45 million. A significant milestone for the company was obtaining FDA approval for its cervical cancer detection technology in December 2018.
Business overview
Biop Medical developed technology for identifying cancerous and precancerous cells in epithelial tissue, specifically focusing on cervical cancer detection. Its core product is a micro-colposcope probe that uses optical phenomena and optomechanical designs to generate a real-time map of the entire cervix, aiming to make colposcopies faster, more comfortable, and more accurate. The company serves the healthcare industry, targeting gynecologists and patients, and operates within the Health Tech & Life Sciences sector, with a focus on Medical Devices and Diagnostics Devices.
Strategic signal
In December 2018, Biop Medical received FDA approval for its cervical cancer detection technology. This regulatory clearance was a critical validation of the company's device, signaling its readiness for broader market adoption and potential impact on early cancer diagnostics within the medical device industry.
Log in to access full profile ›Company Intelligence Q&A
- What is Biop Medical's primary focus?
- Biop Medical focuses on developing technology for the early and accurate detection of cancerous and precancerous cells in epithelial tissue, particularly for cervical cancer.
- When did Biop Medical receive FDA approval for its technology?
- Biop Medical received FDA approval for its cervical cancer detection technology in December 2018.
- What type of technology does Biop Medical utilize?
- Biop Medical's technology uses several optical phenomena and optomechanical designs to enable point-of-care diagnosis and generate a real-time map of the cervix.
- Which investor participated in Biop Medical's April 2016 funding round?
- In April 2016, Shanghai Creative Investments participated in a funding round for Biop Medical.
- What is the status of Biop Medical?
- Biop Medical is currently non-active, having ceased to operate in October 2025.